January 24, 2015 11:10 PM ET

Tobacco

Company Overview of 22nd Century Group, Inc.

Company Overview

22nd Century Group, Inc., a plant biotechnology company, focuses on tobacco harm reduction and smoking cessation products produced from modifying the nicotine content in tobacco plants through genetic engineering and plant breeding. It develops smoking cessation products for smokers who are unable or unwilling to quit smoking; and modified risk tobacco products that reduce exposure to certain tobacco smoke toxins compared to conventional cigarettes. The company’s products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy; RED SUN and MAGIC regular and menthol cigarettes; and SPECTRUM government resear...

9530 Main Street

Clarence, NY 14031

United States

Founded in 1998

9 Employees

Phone:

716-270-1523

Fax:

716-877-3064

Key Executives for 22nd Century Group, Inc.

President
Age: 46
Total Annual Compensation: $159.6K
Chief Financial Officer
Age: 56
Total Annual Compensation: $83.1K
Vice President of R&D
Age: 61
Total Annual Compensation: $124.2K
Compensation as of Fiscal Year 2013.

22nd Century Group, Inc. Key Developments

22nd Century Group, Inc. - Shareholder/Analyst Call

To overview of recent business highlights and a summary of the company's plans for the first half of 2015

22nd Century Group, Inc. Presents at LD Micro Conference, Dec-03-2014 09:30 AM

22nd Century Group, Inc. Presents at LD Micro Conference, Dec-03-2014 09:30 AM. Venue: Luxe Sunset Boulevard Hotel, 11461 Sunset Boulevard, Los Angeles, California, United States.

22nd Century Group, Inc. Announces Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014

22nd Century Group, Inc. announced earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported net loss of $2,724,309 or $0.05 per share compared to $15,372,517 or $0.32 per share a year ago. Adjusted LBITDA was $1,930,650 or $0.03 per share compared to $700,696 or $0.02 per share a year ago. Revenue was $64,000 compared to $52,500 a year ago. The revenues consist of $80,000 generated from the manufacture of filtered cigars, including $64,000 in the third quarter, with the remainder of the revenue generated from the sale of SPECTRUM research cigarettes to the National Institute on Drug Abuse (NIDA), which is part of the National Institutes of Health (NIH), United States Department of Health and Human Services. Operating loss was $2.82 million compared to $1.09 million a year ago. For the nine months, the company reported net loss of $10,005,252 or $0.17 per share compared to $18,331,675 or $0.44 per share a year ago. Adjusted LBITDA was $3,951,833 or $0.07 per share compared to $1,668,248 or $0.04 per share a year ago. Revenue was $528,000. Operating loss was $6.05 million compared to $4.10 million a year ago. The results for the nine months ended September 30, 2014 included non-operating expenses from a non-cash change in the fair value of derivatives (warrant liability) of $3.85 million, a non-cash inducement expense of $145,000 from the amendment of certain warrants, and other net non-operating income of $40,000.

Similar Private Companies By Industry

Company Name Region
Standard Commercial Tobacco Co. Inc. United States
Caribbean Cigar Company United States
Dry Vapes Holdings, Inc. United States
Republic Group, Inc. United States
American Snuff Company, LLC United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
September 17, 2014
--
Private Placement
September 15, 2014
Anandia Laboratories Inc.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact 22nd Century Group, Inc., please visit www.xxiicentury.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.